Latest news with #Dalal
Business Insider
3 hours ago
- Business
- Business Insider
Concord Biotech Ltd. (CONCORDBIO) Receives a Hold from Jefferies
Jefferies analyst Alok Dalal maintained a Hold rating on Concord Biotech Ltd. (CONCORDBIO – Research Report) today and set a price target of INR1,700.00. The company's shares closed yesterday at INR1,748.50. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Dalal covers the Healthcare sector, focusing on stocks such as Ajanta Pharma Limited, Cipla Ltd, and Concord Biotech Ltd.. According to TipRanks, Dalal has an average return of 2.2% and a 55.17% success rate on recommended stocks. The word on The Street in general, suggests a Hold analyst consensus rating for Concord Biotech Ltd..
Hans India
4 days ago
- Sport
- Hans India
'Very excited for the auctions after my performance': Devank Dalal ready to lead PKL 12 auction charge
Mumbai: The Pro Kabaddi League Season 12 auction on May 31 and June 1 are shaping up to be the most blockbuster player draft in league history, with multiple established stars entering the auction pool. Leading this star-studded lineup is Devank Dalal, PKL 11's Best Raider, who scored 301 raid points in 426 raids including 8 Super Raids and 18 Super 10s while leading Patna Pirates to the finals. Despite his stellar achievements, Patna Pirates chose not to retain him, making Dalal one of the most coveted free agents available. "After such an outstanding performance, this is my first auction experience, so I am very excited," Dalal said. His breakthrough season was highlighted by a memorable 26-point performance. "Early in the season, my 26-point match changed my life. I received tremendous encouragement from that performance. That match helped me grow throughout the season." Dalal remains open about his destination preferences. "I can perform well with any team, but there's no guarantee which team will succeed - nothing is predetermined." However, he hasn't ruled out a Patna Pirates reunion: "If Patna Pirates use their Final Bid Match option, then I would return to that team." The auction will separate him from successful raiding partner Ayan Lohchab. "There are supporting raiders in every team, but I will definitely miss Ayan because we had excellent coordination." When it comes to pressure from high price tags, the young raider displayed a certain sense of maturity. "There's no pressure about how much money is involved. The prize money is a good thing, but if there's pressure, then performance suffers. Whatever is written in our destiny, we will get that much." His goals for PKL 12 showcase unwavering ambition: "My personal goal is simple - whichever team I go to, I will give my best. I will perform even better than last year and try to help the team win all the titles."
Business Insider
6 days ago
- Business
- Business Insider
Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)
Jefferies analyst Alok Dalal maintained a Buy rating on Mankind Pharma Ltd. (MANKIND – Research Report) on May 23 and set a price target of INR2,870.00. The company's shares closed last Friday at INR2,425.00. Confident Investing Starts Here: According to TipRanks, Dalal is ranked #4967 out of 9536 analysts. In addition to Jefferies, Mankind Pharma Ltd. also received a Buy from J.P. Morgan's Bansi Desai in a report issued on May 21. However, on the same day, Bank of America Securities maintained a Sell rating on Mankind Pharma Ltd. (NSE: MANKIND).
Business Insider
6 days ago
- Business
- Business Insider
Jefferies Remains a Buy on Emcure Pharmaceuticals Limited (EMCURE)
In a report released on May 23, Alok Dalal from Jefferies maintained a Buy rating on Emcure Pharmaceuticals Limited (EMCURE – Research Report), with a price target of INR1,400.00. The company's shares closed last Friday at INR1,288.65. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Dalal is ranked #4967 out of 9536 analysts. The analyst consensus on Emcure Pharmaceuticals Limited is currently a Hold rating. The company has a one-year high of INR1,577.50 and a one-year low of INR890.00. Currently, Emcure Pharmaceuticals Limited has an average volume of 29.65K.
NDTV
23-05-2025
- Entertainment
- NDTV
Amid The Royals Criticism, Bhumi Pednekar Picks This As Her Favourite Character: "Helped Me Deal With My Insecurities"
Quick Read Summary is AI generated, newsroom reviewed. Bhumi Pednekar recently starred in the Netflix series The Royals. Her versatility and chemistry with Ishaan Khatter received mixed reactions. She considers her character Sandhya from Dum Laga Ke Haisha most significant. New Delhi: Bhumi Pednekar was last seen in the Netflix series The Royals. While some appreciated her versatility and chemistry with Ishaan Khatter, some had mixed responses. Bhumi Pednekar has delivered a mixed bag of projects ever since her debut in Dum Laga Ke Haisha. In a recent conversation with Harper's Bazaar India, the actress revealed that her character Sandhya from her debut film is the closest to her heart. She said, "And the character closest to my heart has to be from my first film, Dum Laga Ke Haisha. Because honestly, that girl changed me. She changed my approach to life. She made me fall a little more in love with myself and helped me deal with my insecurities. It's a never-ending battle. With every passing year, as you grow older, the kinds of insecurities you deal with also change. Every few years, you need some kind of intervention and fortunately for me, my character and my work give me that intervention." Furthermore, talking about some other characters from her filmography that she resonates with the most, Bhumi shared, "I think a character I resonated with the most has to be a mix of what I did in Thank You for Coming and Badhaai Do. I think both these pieces centred around themes of liberation, finding freedom, standing your ground, and being your most authentic self. And to me, these are things that really, really matter because I honestly have been on that path over the last decade. The kind of roles I've done have always reflected my pursuit of that liberation and freedom." On the work front, Bhumi is all set to headline a thriller, she now has Dalal in her lineup.
